China Independent Clinical Laboratory Industry Report, 2014-2017
  • Oct.2014
  • Hard Copy
  • USD $2,000
  • Pages:78
  • Single User License
    (PDF Unprintable)       
  • USD $1,850
  • Code: ZLC010
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,850
  • Hard Copy + Single User License
  • USD $2,200

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there was around RMB3.5 billion, up as much as 70% yr-on-yr, yet only accounting for 2%-3% of the total revenue of medical diagnosis.

There are about 110 independent clinical laboratories in today’s China, but most of them are small sized. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene as the strong performers thereof hold a combined market share of roughly 70%.

Because of a high requirement on the samples within a shorter time limit for place, the industry has a certain service radius. Therefore, a national layout is essential to business development and customer acquisition and chain-orientation the key development mode, for enterprises. KingMed Diagnostics, ADICON, DIAN Diagnostics and DAAN Gene have by far 19, 15, 14 and 8 independent medical laboratories across the country.

KingMed Diagnostics as the largest independent clinical laboratory enterprise in China enjoys a market share of approximately 40%, receiving recognition from both College of American Pathologists (CAP) and ISO15189. In the first half of 2014 it posted revenue of RMB846 million, up 37% yr-on-yr. Equipped with detection platforms for tumor diseases, genetic diseases, blood diseases, etc., KingMed Diagnostics will give top priority to tumor, reproduction and microbiological testing in the future.

ADICON is the first independent medical laboratory in domestic trans-regional chain operation, with a market share as high as 15%-18%. In recent years, many of its subsidiaries have successively won ISO15189 and CAP certificates

As an industry leader in the business model of "service + agent", DIAN Diagnostics gets involved in independent clinical laboratory, judicial expertise, diagnostic products agency and other areas. Currently, the company boasts an 18% market share in the Chinese independent clinical laboratory industry, capable of carrying out more than 1,000 medical diagnostic services.

Moreover, related enterprises abroad have also been well aware of the growth potential in China’s independent clinical laboratory industry, and set foot in the Chinese market via cooperation with local companies.

In February 2012, Quest and KingMed Diagnostics entered into a strategic alliance and established the KingMed&Quest Diagnostics Alliance Laboratory. And the Tianbo Lab jointly set up bythe South Korea-based SK Group and Xi’an Tianlong Science & Technology Co.Ltd started business in July 2014.

第三方实验室 英文_副本.png

China Independent Clinical Laboratory Industry Report, 2014-2017 highlights the followings:
20120114.gifPolicy environment, international market, development status, competition pattern, etc. of China’s independent clinical laboratory industry;
20120114.gifUpstream and downstream markets of China’s independent clinical laboratory industry and their impacts;
20120114.gifOperation, independent clinical laboratory business, etc. of 13 relevant enterprises in China;
20120114.gifProspect for the development of China’s independent clinical laboratory industry in 2014-2017 and operation comparison between key players.

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Market
2.2.1 Status Quo
2.2.2 Benchmarking Enterprises
2.3 Development Status
2.4 Competition Pattern

3. Upstream and Downstream Markets of China Independent Clinical Laboratory Industry
3.1 Upstream Market
3.1.1 Status Quo
3.1.2 Competition Pattern
3.2 Downstream Market
3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
3.2.2 Healthcare Reform Boosts the Rapid Development of Independent Clinical Laboratory Market
3.2.3 Demand Diversification Promotes the Upgrading of Independent Clinical Laboratory Industry
3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster

4. Key Players
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Independent Clinical Laboratory
4.1.3 Operation and Development
4.2.1 Profile
4.2.2 Independent Clinical Laboratory
4.2.3 Development
4.3 DIAN Diagnostics
4.3.1 Profile
4.3.2 Operation 
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory
4.3.7 Supply and Sales
4.3.8 Forecast and Outlook
4.4 DAAN Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D and Investment
4.4.6 Independent Clinical Laboratory
4.4.7 Supply and Sales
4.4.8 Forecast and Outlook
4.5 NYMPHAVN Biotechnology
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Independent Clinical Laboratory
4.5.7 Forecast and Outlook
4.6 SurExam
4.6.1 Profile
4.6.2 Operation
4.6.3 Gross Margin
4.6.4 Independent Clinical Laboratory
4.6.5 Supply and Sales
4.6.6 Forecast and Outlook
4.7 Amoy Diagnostics
4.7.1 Profile
4.7.2 Independent Clinical Laboratory
4.8 CapitalBio
4.8.1 Profile
4.8.2 Independent Clinical Laboratory
4.9.1 Profile
4.9.2 Independent Clinical Laboratory
4.10 Kindstar Global
4.10.1 Profile
4.10.2 Independent Clinical Laboratory
4.11 Deyi Diagnostics
4.11.1 Profile
4.11.2 Independent Clinical Laboratory
4.12 IPE-Bio
4.12.1 Profile
4.12.2 Independent Clinical Laboratory

5. Forecast and Outlook
5.1 Industry Development
5.2 Operation Comparison between Enterprises
5.2.1 Revenue
5.2.2 Net Income
5.2.3 Net Profit Margin
5.2.4 Gross Margin
5.2.5 Independent Clinical Laboratory
Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2013
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Revenue and Net Income of Quest, 2009-2014
Gross Margin of Quest, 2009-2014
Major M&A Events of Quest Diagnostics, 2006-2014
Revenue and Operating Income of LabCorp, 2010-2013
Revenue Breakdown of LabCorp by Business, 2010-2013
Major M&A Events of LabCorp, 2007-2013
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2014
Market Size of In Vitro Diagnostic Industry in China, 2009-2013
Market Structure of In Vitro Diagnostic Industry in China, 2013
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013
Business Revenue and Inspection Revenue of Medical Institutions in China, 2012
Medical Services of Health Agencies in China, 2012-2013
Number of Medical Institutions in China, 2012-2013
Health Expenditure and % of GDP in China, 1980-2013
Per Capita Health Expenditure and YoY Growth in China, 2006-2013E
Revenue of KingMed Diagnostics, 2012-2014
Revenue and Net Income of DIAN Diagnostics, 2009-2014
Revenue Breakdown of DIAN Diagnostics by Product, 2009-2014
Revenue Structure of DIAN Diagnostics by Product, 2009-2014
Revenue Breakdown of DIAN Diagnostics by Region, 2009-2014
Gross Margin of DIAN Diagnostics, 2009-2014
R&D Costs and % of Total Revenue of DIAN Diagnostics, 2010-2014
DIAN Diagnostics’ Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
Name List and Procurement of DIAN Diagnostics’ Top 5 Suppliers, H1 2014
Name List and Procurement of DIAN Diagnostics’ Top 5 Suppliers, 2013
Name List and Sales of DIAN Diagnostics’ Top 5 Clients, H1 2014
Name List and Sales of DIAN Diagnostics’ Top 5 Clients, 2013
Revenue and Net Income of DIAN Diagnostics, 2012-2017E
Revenue and Net Income of DAAN Gene, 2009-2014
Revenue Breakdown of DAAN Gene by Business, 2009-2014
Revenue Structure of DAAN Gene by Business, 2009-2014
Revenue Breakdown of DAAN Gene by Region, 2009-2014
Revenue Structure of DAAN Gene by Region, 2009-2014
Gross Margin of DAAN Gene, 2009-2014
Gross Margin of DAAN Gene by Business, 2009-2014
R&D Costs and % of Total Revenue of DAAN Gene, 2011-2014
Main Assets and Business of DAAN Gene
Industrial Chain Layout of DAAN Gene
Medical Resources of Sun Yat-Sen University
DAAN Gene’s Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2014
Top 5 Clients of DAAN Gene, H1 2014
Top 5 Clients of DAAN Gene, 2013
Top 5 Suppliers of DAAN Gene, 2013
Top 5 Suppliers of DAAN Gene, 2012
Revenue and Net Income of DAAN Gene, 2012-2017E
Revenue and Net Income of NYMPHAVN Biotechnology, 2009-2014
Revenue Breakdown of NYMPHAVN Biotechnology by Product, 2009-2014
Revenue Structure of NYMPHAVN Biotechnology by Product, 2009-2014
Gross Margin of NYMPHAVN Biotechnology, 2009-2014
Gross Margin of NYMPHAVN Biotechnology by Product, 2009-2014
Revenue and Gross Margin of Independent Clinical Laboratory of NYMPHAVN Biotechnology, 2009-H1 2014
Revenue and Net Income of NYMPHAVN Biotechnology, 2012-2017E
Revenue and Net Income of SurExam, 2011-2014
Gross Margin of SurExam, 2011-2014
Name List and Revenue of SurExam’s Top 5 Clients, 2011-2013
Name List and Procurement of SurExam’s Top 5 Suppliers, 2011-2013
Revenue and Net Income of SurExam, 2012-2017E
Some Strategic Partners of ADINOVO
Major Events of Kindstar Global
Revenue of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Net Income of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Net Profit Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Gross Margin of Major Independent Clinical Laboratory Enterprises in China, 2009-2014
Revenue from Independent Clinical Laboratory of Major Independent Clinical Laboratory Enterprises in China, 2009-2014

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号